.png)
Public Research
Studies
Original, data-rich research that equips healthcare leaders with
authoritative insights into trends shaping the health economy.
authoritative insights into trends shaping the health economy.
.png)
Despite Regulatory Scrutiny, Increases in Adult ADHD Diagnosis and Off-Label Stimulant Prescribing Continued Through 2023
In 2018, 86.4% of stimulant recipients had an ADHD diagnosis in their medical claims, but by 2023, this percentage had dropped to 57.0%.